These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 31921115)

  • 21. Clusters in Behçet's syndrome.
    İlgen U
    Arthritis Res Ther; 2022 Oct; 24(1):242. PubMed ID: 36309718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cluster analysis of paediatric Behçet's disease: Data from The Pediatric Rheumatology Academy-Research Group.
    Demir F; Sönmez HE; Bağlan E; Akgün Ö; Coşkuner T; Yener GO; Öztürk K; Çakan M; Karadağ ŞG; Özdel S; Ayaz NA; Sözeri B
    Mod Rheumatol; 2023 Apr; 33(3):574-578. PubMed ID: 35534229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet's Syndrome and Psoriatic Arthritis.
    Bettiol A; Fagni F; Mattioli I; Bagni G; Vitiello G; Grassi A; Della Bella C; Benagiano M; Troilo A; Holownia KS; Simon D; Argento FR; Sota J; Fabiani C; Becatti M; Fiorillo C; Schett G; Lopalco G; Cantarini L; Prisco D; Silvestri E; Emmi G; D'Elios MM
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular complications of Behçet disease.
    Tazi Mezalek Z; Khibri H; Chadli S; El Fari S; Ammouri W; Harmouche H; Maamar M; Adnaoui M
    Minerva Med; 2021 Dec; 112(6):767-778. PubMed ID: 35168306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Currently Used Biologic Agents in the Management of Behcet's Syndrome.
    Saygin C; Uzunaslan D; Hatemi G
    Curr Med Chem; 2015; 22(16):1976-85. PubMed ID: 25666786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biotherapies in Behçet's disease.
    Comarmond C; Wechsler B; Bodaghi B; Cacoub P; Saadoun D
    Autoimmun Rev; 2014 Jul; 13(7):762-9. PubMed ID: 24473176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in interferon: A treatment of Behcet syndrome].
    Yan D; Zheng WJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1166-1170. PubMed ID: 33331331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behçet's syndrome.
    Yurdakul S; Yazici H
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):793-809. PubMed ID: 19028364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behçet's syndrome: facts and controversies.
    Mat C; Yurdakul S; Sevim A; Özyazgan Y; Tüzün Y
    Clin Dermatol; 2013; 31(4):352-361. PubMed ID: 23806152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis.
    Siva A; Saip S
    J Neurol; 2009 Apr; 256(4):513-29. PubMed ID: 19444529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behçet's syndrome: a critical digest of the 2014-2015 literature.
    Hatemi G; Seyahi E; Fresko I; Talarico R; Hamuryudan V
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S3-14. PubMed ID: 26487500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recommendations for the diagnosis and treatment of Behçet's syndrome in China].
    Zheng WJ; Zhang N; Zhu XC; Chi SS; Zhang W; Wei W; Zhao Y; Dong Y
    Zhonghua Nei Ke Za Zhi; 2021 Oct; 60(10):860-867. PubMed ID: 34551473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of Behçet's syndrome.
    Seyahi E; Fresko I; Melikoglu M; Yazici H
    Acta Reumatol Port; 2006; 31(2):125-31. PubMed ID: 17058358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome.
    Talarico R; Palagini L; d'Ascanio A; Elefante E; Ferrari C; Stagnaro C; Tani C; Gemignani A; Mauri M; Bombardieri S; Mosca M
    CNS Drugs; 2015 Mar; 29(3):189-96. PubMed ID: 25643894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behçet's disease--clinical presentation, diagnostic and therapeutic approach].
    Elbirt D; Asher I; Sthoeger ZM
    Harefuah; 2002 May; 141(5):462-7, 497. PubMed ID: 12073530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct clinical characteristics of pediatric Behçet's syndrome: A study from a referral center in China.
    Zou J; Luo JF; Shen Y; Guan JL
    Mod Rheumatol; 2021 Nov; 31(6):1158-1163. PubMed ID: 33627024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current management options in Behçet's disease.
    Andrews J; Haskard DO
    Minerva Med; 2002 Oct; 93(5):335-45. PubMed ID: 12410166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuro-Behçet's syndrome: differential diagnosis and management.
    Diri E; Espinoza LR
    Curr Rheumatol Rep; 2006 Aug; 8(4):317-22. PubMed ID: 16839512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to guidelines for the treatment of Behçet's syndrome in New York and Amsterdam.
    Kerstens FG; Turkstra F; Atalay S; van Vugt RM; Swearingen CJ; Yazici Y
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):55-59. PubMed ID: 28406760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ocular manifestations in Behçet's disease].
    Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
    Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.